Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
50.0%
% of PBE's 28 holdings also in WDNA
16.5%
% of WDNA's 90 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 5.4% | 4.0% | 4.0% |
|
BLUEPRINT MEDICINES CORP. | 2.6% | 2.5% | 2.5% |
|
VERACYTE INC | 2.8% | 2.5% | 2.5% |
|
UNITED THERAPEUTICS CORP | 5.0% | 1.8% | 1.8% |
|
SAREPTA THERAPEUTICS INC | 3.0% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to WDNA
|
INCYTE CORP | 4.8% |
|
BIOGEN IDEC INC | 4.1% |
|
ILLUMINA INC | 3.7% |
|
REGENERON PHARMACEUTICALS | 3.6% |
|
GILEAD SCIENCES INC | 3.5% |
|
AMGEN INC | 3.2% |
|
UNITED THERAPEUTICS CORP | 3.1% |
|
ROYALTY PHARMA PLC CLASS A | 3.1% |
|
NEUROCRINE BIOSCIENCES INC | 3.0% |
|
HALOZYME THERAPEUTICS INC | 3.0% |
PBE Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -3.8% |
 |
NOVOZYMES A/S-B SHARES | -3.5% |
|
VERICEL CORPORATION | -2.8% |
|
ELI LILLY & CO | -2.3% |
|
GERON CORP | -2.1% |
|
BRIDGEBIO PHARMA, INC. | -2.0% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.6% |
|
ALNYLAM PHARMACEUTICALS INC | -1.5% |
|
NEOGENOMICS INC | -1.5% |